Early life parechovirus infection: a timely review but many questions remain
| Field | Value | Language |
| dc.contributor.author | Britton, Philip N | en |
| dc.contributor.author | Jones, Cheryl A | en |
| dc.date.accessioned | 2020-08-14 | |
| dc.date.available | 2020-08-14 | |
| dc.date.issued | 2020 | en |
| dc.identifier.uri | https://hdl.handle.net/2123/23048 | |
| dc.description.abstract | Species A parechoviruses (human parechoviruses), and most prominantly Species A parechoviruses type 3, are now recognised as a leading causes of fever, sepsis-like illness, and CNS infection in young infants (aged <3 months). Although mortality is infrequent, and short-term recovery is common, there have been several studies showing longer-term neurological morbidity following parechovirus infection in infancy. The frequency of and risk factors for adverse neurological outcomes remain inadequately defined. | en |
| dc.language.iso | en | en |
| dc.rights | Other | |
| dc.subject | COVID-19 | en |
| dc.subject | Coronavirus | en |
| dc.title | Early life parechovirus infection: a timely review but many questions remain | en |
| dc.type | Article | en |
| dc.identifier.doi | 10.1016/s2352-4642(20)30180-2 | |
| usyd.faculty | Faculty of Medicine and Health, Sydney Medical School | en |
Associated file/s
There are no files associated with this item.
Associated collections